References
- NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65–9
- Dixon J S. Helicobacter pylori eradication: unravelling the facts. Scand J Gastroenterol 1995; 30(Suppl 212)48–62
- Maniatis A G, Brazer S R. Omeprazole/amoxicillin versus raniti-dine/triple therapy for duodenal ulcer: when is the 'same' the same?. Am J Gastroenterol 1994; 89: 947–8
- Gotz J M, Veenendaal R A, Veselic M, Bernards S, Lamers C BHW. Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori. Scand J Gastroenterol 1995; 30(Suppl 212)34–7
- De Boer W A, Driessen W MM, Potters H VPJ, Tytgat G NJ. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994; 89: 1993–7
- Graham D Y, Lew G M, Evans D G, Evans D J, Jr, Klein P D. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991; 115: 266–9
- Hentschel E, Brandstatter G, Dragosics B, Hirschl A M, Nemec H, Schütze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308–12
- Baxter A, Campbell C J, Clayton N M, Clitherow J W, McColm A A, Stables R. Ranitidine bismuth citrate, a novel compound possessing gastric antisecretory, mucosal protective, anti-pepsin and mti-Helicobacter properties. Gut 1991; 32: A25